Veracyte (VCYT) Gross Profit (2012 - 2026)

Veracyte has reported Gross Profit for 15 years, with the latest figure at $108.5 million in Q2 2026.

• Gross Profit for Q2 2026 came in at $108.5 million, up 20.92% year-over-year; the trailing twelve-month figure through Jun 2026 was $403.0 million (up 23.21% YoY), and the FY2025 annual result was $362.5 million, up 21.6% from the prior year.
• Gross Profit grew to $108.5 million in Q2 2026, from $101.2 million in the prior quarter.
• Over five years, Gross Profit peaked at $108.5 million in Q2 2026 and troughed at $50.3 million in Q1 2022.
• A 5-year average of $74.0 million and a median of $71.4 million in 2023 frame the typical range for Gross Profit.
• The widest annual swing landed in 2022, when Gross Profit surged 94.27%; it then retreated 0.49% in 2024.
• A 5-year view of Gross Profit shows it stood at $60.9 million in 2022, then gained by 6.38% to $64.8 million in 2023, then gained by 21.56% to $78.8 million in 2024, then gained by 29.48% to $102.0 million in 2025, then climbed by 6.45% to $108.5 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $108.5 million in Q2 2026, $101.2 million in Q1 2026, and $102.0 million in Q4 2025.